Hepatocellular carcinoma represents a classic example of inflammation-linked cancer. To characterize the role of the immune system in hepatic injury and tumor development, we comparatively studied the extent of liver disease and hepatocarcinogenesis in immunocompromised vs.
Introduction
Hepatocellular carcinoma (HCC) is one of the most lethal and prevalent cancers worldwide and has recently become the second most common cause for cancer related death in humans. In contrast to many other cancers, its incidence increases annually by 1.75% in the western world.
HCC is commonly caused by hepatitis B and C infections (~75%), and less frequently associated with chronic exposure to toxins or hereditary liver diseases (El-Serag et al., 2008) . Although many studies have reported significant alterations in inflammatory cells and in the expression of different cytokines in liver cirrhosis and HCC, the critical components linking inflammation and hepatocarcinogenesis are only beginning to be unraveled.
The liver is heavily populated by immune cells, including macrophages, NK, NKT cells, CD4 + and CD8 + T cells. The co-residence of these immune cells in the liver creates a unique environment that regulates liver homeostasis. Experimental studies with rodents suggest that T and NK cells are not only required to eliminate pathogenic microorganisms, but that they also regulate liver regeneration by supporting proliferation of hepatocytes and hepatic progenitor cells under non-infectious conditions (Strick-Marchand et al., 2004; Tumanov et al., 2009 ). Moreover, sustained inflammation may not only create an environment in which the continuous presence of pro-proliferative stimuli ultimately leads to liver fibrosis and cirrhosis, but may also contribute to the malignant transformation of hepatocytes. In this regard, there is evidence that lymphocytederived cytokines such as lymphotoxin-β (LTβ) and TNFα are involved in viral hepatitis and cholestasis induced hepatocarcinogenesis, as well as in the progression of non-alcoholic steatohepatitis to HCC (Haybaeck et al., 2009; Pikarsky et al., 2004; Wolf et al., 2014) .
On the contrary, the immune system is able to launch a potent anti-tumor response in the process of liver carcinogenesis, exemplified by the observation that progression of hepatic tumors is strikingly enhanced in T and B cell-deficient Rag1 -/-mice upon treatment with the chemical carcinogen DEN (Schneider et al., 2012) . Similarly, impaired immune surveillance of premalignant senescent hepatocytes has been shown to lead to the development of murine HCCs suggesting that senescence surveillance is important for tumor suppression in the liver (Kang et al., 2011; Ma et al., 2016) .
To further delineate the role of the immune system in the liver during chronic injury and to specify its role in the initiation and progression of HCC, we used a mouse model of hereditary tyrosinemia type 1 (HT1). HT1 is an autosomal-recessive human disease caused by a genetic inactivation of the enzyme fumarylacetoacetate hydrolase (FAH), which catalyzes the last step in the tyrosine degradation and is predominantly expressed in liver and kidneys. This defect leads to 4 Endig J et al. an accumulation of toxic metabolites such as fumarylacetoacetate (FAA), which subsequently causes acute and chronic liver failure (Grompe et al., 1993) . The drug NTBC (2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione, or Nitisinone), which blocks the pathway upstream of FAA formation, is used to treat patients with HT1 and prevents liver injury in Fah -/-mice (Grompe et al., 1995; Mayorandan et al., 2014) . The murine model of Fah-deficiency reliably mirrors the inflammatory environment of the human disease, and is therefore suitable to delineate the divergent roles of immune cells in chronic liver injury and has been extensively used to study liver carcinogenesis and regeneration (Buitrago-Molina et al., 2009; Marhenke et al., 2008; Willenbring et al., 2004; Willenbring et al., 2008) . 5 Endig J et al.
Results

Activation of the intrahepatic immune cells in FAA-induced liver injury
HCC represents a classic case of inflammation-linked cancer and chemically or genetically induced HCC is highly dependent on inflammatory signaling. Repeated flares of injury typically characterize chronic human liver diseases. Using the FAH model as a surrogate for chronic liver disease, we first aimed to phenotype the infiltrating immune cells upon repeated FAA-induced liver injury. As detailed described in the supplementary Figure S1 , NTBC was withdrawn for three weeks, and subsequently re-administered for five days to allow recovery and liver regen- and FCR mice were comparatively analyzed following the second course of NTBC withdrawal.
As expected, H&E staining revealed moderate to severe acinar inflammation, numerous ballooned and some dysplastic hepatocytes with nuclear polymorphism and multi-nucleation in Fah -/-mice without NTBC (0%) treatment ( Figure 2B ). Necrosis was the main mechanism of hepatocyte death and there was hardly any evidence of apoptosis with only a few scattered TUNEL-and cleaved Caspase 3-positive hepatocytes ( Figure 2C ). Elevated bilirubin and aspartate transaminase (AST) levels accompanied histological liver injury ( Figure 2D , E). In contrast, liver damage was significantly reduced in the surviving FCR mice. To histologically quantify and compare chronic liver injury, the modified Ishak-Score was assessed, further confirming a markedly increased histological remodeling in the livers of Fah -/-mice as compared to immunosuppressed FCR mice ( Figure 2E ). Accordingly, bilirubin and transaminase levels were only marginally increased in the serum of FCR mice ( Figure 2D , E). We have previously shown that FAAinduced liver damage leads to a strong, protective activation of the Nrf2 pathway, reflected by the increased expression of NAD(P)H dehydrogenase 1 (NQO1) and heme oxigenase-1 (HO-1) (Marhenke et al., 2008) . Both proteins were significantly up-regulated in livers of cycled Fah -/-and FCR mice ( Figure S2 ) indicating that hepatocytes in Fah -/-and FCR mice experience a similar degree of oxidative stress inflicted by the accumulation of FAA.
Long-term FAA-induced liver injury caused progressive biliary fibrosis in Fah -/-mice. Extensive interstitial collagen deposition, determined by Sirius Red staining, and an increase of α-SMA positive stellate cells was evident in Fah -/-mice after 6 courses of NTBC withdrawal ( Figure 2F ).
The degree of fibrosis was quantified by measuring the hepatic content of hydroxyproline, which was significantly elevated in livers of cycled Fah -/-mice compared to healthy mice on 100% NTBC ( Figure 2F , p≤0.05). In agreement with the significantly reduced liver damage, there was no evidence of liver fibrosis in FCR mice ( Figure 2F ).
In order to understand the increased mortality in FCR mice despite less pronounced liver injury in mice with long-term survival, several mice were harvested when showing signs of rapidly deteriorating health and weight loss of more than 20%. Macroscopically, livers of moribund mice appeared pale. Contrary to our observations in healthy FCR mice undergoing NTBC withdrawal, H&E and TUNEL staining revealed massive hepatic necrosis and apoptosis without any signs of liver regeneration suggesting that these mice died from acute on chronic liver failure ( Figure 2G ).
Areas of liver necrosis were surrounded and infiltrated by neutrophils. Livers from moribund mice of both cohorts showed a comparable histology, independent of whether the mice required sacri- Figure 3A , B). In the recovery phase, a dramatic increase of proliferating hepatocytes was evident ( Figure 3A ) (Ki67 labeling index of 36.6% in mice re-supplemented with NTBC compared to 0% in mice taken off NTBC, p≤0.05). These findings were further confirmed by increased BrdU incorporation and histone H3 phosphorylation (data not shown). Comparable results were obtained in FCR mice upon NTBC withdrawal and reconstitution. However, in agreement with the reduced liver injury in FCR mice, the proliferation rate of hepatocytes in response to NTBC re-supplementation was significantly lower as compared to Fah -/-mice ( Figure 3A , p≤0.05).
It is generally accepted that increased proliferation of hepatocytes is a key contributor to liver regeneration. In addition, hypertrophy of hepatocytes was recently identified as an additional mechanism of liver regeneration following partial hepatectomy. The circumference of hepatocytes can be visualized by β-Catenin staining and hepatocytes can be distinguished from other non-parenchymal cells based on their size ( Figure 3C ). Quantitative analysis revealed that the size of hepatocytes more than doubled in Fah -/-mice taken off NTBC. Accordingly, the number of hepatocytes significantly dropped by more than 50% per field of vision in Fah -/-mice ( Figure   3C ). Liver weight of Fah -/-mice decreased by 24% indicating loss of more than 60% of hepatocytes upon NTBC withdrawal (data not shown). During NTBC re-treatment, the size of hepato- cytes slightly decreased and hepatocyte counts slightly increased compared to mice off NTBC.
Intriguingly, cell size and number were maintained in FCR mice during NTBC cycling in agreement with the reduced liver injury ( Figure 3C ).
Considering that liver progenitor cells (LPCs) located within the smallest branches of the intrahepatic biliary tree are activated upon liver injury, we decided to assess the presence of progenitor cells in Fah -/-and FCR mice using established LPC markers A6 and MIC1-1C3 (Dorrell et al., 2011) . Importantly, these markers are also expressed by regular cholangiocytes, serving as an internal staining control (Tarlow et al., 2014) . Indeed, a marked increase of A6 positive LPCs was present in the livers of Fah -/-mice ( Figure 3D Figure 3E ). Notably, the LPC response was completely abrogated in cycled FCR mice suggesting that the immune system is required for activation of LPCs ( Figure 3D , E).
To better understand how the immune system modulates the cellular stress response and to identify gene expression profiles, microarray analysis and Gene Set Enrichment Analysis was performed on livers from cycled Fah -/-and FCR mice and their respective controls. The most significantly differently regulated categories in cycled Fah -/-compared to cycled FCR mice and to healthy Fah -/-mice on 100% NTBC were related to "cell cycle" in agreement with the strong proliferative response in the recovery phase of Fah -/-mice ( Figure 3F ).
Together, these data indicate that liver regeneration during chronic injury is accomplished by proliferation of hepatocytes, hepatocyte hypertrophy and activation of LPCs. Liver regeneration by self-duplication of hepatocytes is not impaired in immunosuppressed Fah -/-mice, whereas the immune system is required for full activation of the LPC response.
The adaptive immune system is not required for cell cycle progression in Fah-deficient hepatocytes in response to partial hepatectomy or following hepatocyte transplantation
Based on experiments in Rag2 -/-mice, which are devoid of B, T and NKT cells, Tumanov and colleagues postulate that the adaptive immune system is required for liver regeneration in wild type (WT) mice following partial hepatectomy (El-Serag et al.) (Tumanov et al., 2009 compromise survival following PH ( Figure 4A ). Moreover, recovery of liver mass one week following PH was similar in both groups confirming that there is no significant impact on liver regeneration following PH in immunocompromised Fah -/-mice ( Figure 4A ). As expected, multiple Ki67 + cells were clearly visible 37 hours after PH in 3-month-old Fah −/− mice, as well as in FCR mice. There was no significant difference in the Ki67 labeling index between the immunocompetent and immunocompromised cohort ( Figure 4B ). Figure 4C ). Thus, the transplantation experiments confirmed that the adaptive immune system is not required for effective engraftment and proliferation of hepatocytes in livers with chronic injury.
Tumor development is markedly suppressed in immunodeficient Fah -/-mice with chronic liver injury
To study the role of the immune system in chronic FAA-induced liver injury, livers were analyzed following the second, fourth and sixth cycle of NTBC withdrawal. Several studies suggest that most malignant tumors are most likely derived from single progenitor cells that have acquired genetic and epigenetic changes that allow clonal expansion. Recently, CD44 + HCC progenitor cells have been identified in different HCC mouse models (He et al., 2013) . In contrast to HCCderived cancer cells, these progenitor cells solely give rise to tumors in mice with chronic liver injury. In our model, liver sections from Fah -/-mice showed the progressive appearance of CD44v6 + cells whereas these cells did not increase in immunosuppressed mice, suggesting that FAA-induced liver injury only gives rise to bona fide HCC initiating cells in immune competent mice ( Figure 5A ).
Ongoing proliferation of hepatocytes and progenitor cells during the recovery phase allowed rapid progression to frank HCCs. 33% of Fah -/-mice had already developed small tumor nodules after the second cycle (n=22). After the fourth and sixth cycle, HCCs were present in all mice (n=28) ( Figure 5B, C), and tumor growth was accompanied by a significant increase in liver weight after the sixth cycle ( Figure 5D , E). By this time, mean size of the largest tumor nodule 10 Endig J et al.
per liver had increased from 5.6 mm after the second cycle to 8.8 mm ( Figure 5E ). Histological examination of the livers confirmed the presence of numerous dysplastic hepatocytes and moderate to well-differentiated HCCs with fatty changes and solid growth pattern ( Figure 5F ). Multiple Ki67 + and AFP + tumor cells were observed within the tumor lesions. A6 + and CD44v6 + cells surrounded the tumors at the border zone, but were not present within the tumors ( Figure 5A , F).
In contrast, HCC development was significantly reduced in FCR mice, with only 12% harboring detectable tumors within the first sixth cycle ( Figure 5B, C) . Accordingly, liver weight and mean size of tumors were significantly lower in these mice compared to the Fah -/-mice ( Figure 5D , E).
Microdissected HCCs (n=8) and age-matched control livers (n=4) were investigated for chromosomal aberrations by array comparative genomic hybridization analysis (aCGH). The most common loss that was present in all 8 profiles was a small region on chromosome 15 (gene Figure 6B ). Finally, the LPC response was abrogated in all mice that lacked T cells as indicated by the absence of A6 expressing cells ( Figure   6B ). In contrast, T cell transplantation was sufficient to stimulate an LPC response in FCR and FR mice. Moreover, LPCs were readily detectable in Fβ2m mice suggesting that CD4 + T cells, which have previously been shown to co-localize with expanding and migrating oval cells (StrickMarchand et al., 2008) , are sufficient to activate LPCs during chronic liver injury.
Together, these data highlight the dual role of T cells in liver injury and HCC development.
T cells are required to protect mice from the increased mortality observed in alymphoid mice. On the contrary, activation of T cells significantly contributes to liver injury and promotes tumor development. CD4 + T cells are specifically required to allow LPC expansion in mice with chronic liver injury, whereas absence of adaptive immune cells does not preclude normal hepatocyte proliferation.
CD8 + T cells are required for FAA-induced hepatocarcinogenesis
Next, we set out to determine whether tumor development could be delayed in Fah Gene profiling identified a cluster of genes including lymphotoxin-β, Ccl17, Ccl20 and Ccl22 LTβ has previously been shown to induce hepatotoxicity and promote carcinogenesis in the liver (Haybaeck et al., 2009; Wolf et al., 2014) . In order to investigate the role of LTβR in the transition from chronic liver injury to HCC, LTβ signaling was blocked using a LTβ receptor immunoglobulin fusion protein (LTβR-Ig). Two-month-old Fah -/-mice were exposed to two courses of 
Discussion
Hepatocellular carcinoma is one of the most lethal and prevalent cancers worldwide and frequently arises in the presence of chronic injury and inflammation. It is commonly associated with viral hepatitis, chronic exposure to toxins or hereditary liver diseases (Kirstein and Vogel, 2014 ).
The immune system serves an important role in guarding organ homeostasis in the face of exposure to toxins and hepatotrophic viruses. Lately, the immune system has increasingly been recognized as a key contributor to tumor initiation and progression, yet the precise molecular mechanisms remain elusive.
In this study, we analyze the molecular events occurring during liver cancer initiation using a well-established mouse model of chronic liver injury and hepatocarcinogenesis (Buitrago- Molina et al., 2013; Buitrago-Molina et al., 2009; Grompe et al., 1993; Grompe et al., 1995; Marhenke et al., 2008; Vogel et al., 2004) . Our data unveil that apart from their role in maintaining hepatic inflammation, the presence or absence of T cells is decisive for tumor development in chronic liver injury. Mechanistically, we provide evidence that CD8 + T cell and lymphotoxin-β drive the malignant transformation of hepatocytes.
HT1 is caused by genetic inactivation of the last step in tyrosine metabolism leading to the accumulation of the metabolite FAA. FAA is a thiol-reacting and organelle/ mitotic spindledisturbing agent with mutagenic activities. Hence, liver injury in HT1 deficient organisms has been mainly attributed to immediate toxicity of the metabolite (Jorquera and Tanguay, 2001 ).
Our work demonstrates that chronic liver damage and hepatocyte destruction is predominantly mediated by the adaptive immune system. This concept is supported by a presumed role of lymphocytes in mounting an immune response that promotes hepatic damage in diverse liver diseases such as acetaminophen-induced liver failure or chronic hepatitis B and C infection (Adams et al., 2010; Rehermann, 2013) .
Although T cells set the stage for chronic liver injury, they actually protect mice from acute on chronic liver failure. Consistent with the notion that the adaptive immune system helps to prevent acute liver failure, adoptively transferred T cells reduce the high mortality of immunosuppressed Fah-deficient mice. The exact reason for the high mortality in FCR mice remains elusive. Interestingly, however acute liver failure in our model closely resembles acute on chronic liver failure (ACLF) in humans with chronic liver diseases. ACLF is an increasingly recognized syndrome in patients with chronic liver diseases characterized by acute deterioration of cirrhosis, organ failure and extremely poor survival (Arroyo et al., 2015 Liver injury is generally accompanied by compensatory liver regeneration, which can be accomplished through hepatocyte hypertrophy, hepatocyte proliferation and activation of LPCs. Previous studies have suggested that the immune system impairs liver regeneration in healthy mice following PH (Tumanov et al., 2009 FAA-induced liver injury causes rapid onset of HCC in men (Mayorandan et al., 2014) . Similarly, Fah-deficient mice develop HCC on low dose NTBC within 12 months (Marhenke et al., 2008) . We postulate that acceleration of tumor onset is most likely related to the strong inflammationinduced proliferative response during the recovery phase. This hypothesis is supported by recent reports showing that the synergistic action of inflammation-induced cell proliferation and DNA damaging environmental agents cause DNA sequence rearrangements that culminate in 16 Endig J et al. cancer formation (Kiraly et al., 2015) . Recently, CD44 + HCC progenitor cells were identified in several HCC mouse models (He et al. Cell 2013) . In contrast to HCC-derived cancer cells, these progenitor cells solely give rise to tumors in mice with chronic liver injury. In our model, liver sections from Fah -/-mice showed the progressive appearance of CD44v6 + cells whereas these cells did not increase in immunosuppressed mice, suggesting that FAA-induced liver injury only gives rise to bona fide HCC initiating cells in immune competent mice.
Suppression of the immune system is commonly regarded as a risk factor for the development of de novo malignancies in patients, likely related to an increased susceptibility to infections with oncogenic viruses such as Epstein-Barr or human papilloma viruses (Schrem et al., 2013) . Strikingly, tumor development was markedly reduced in genetically immunocompromised Fah -/-mice. (Ma et al., 2016) . In contrast, metabolic activation of intrahepatic NKT and CD8 + T cells by lipids has been shown to induce hepatotoxicity and promote NASH-driven hepatocarcinogenesis (Wolf et al., 2014) . Together, these data indicate that CD4 + cells and myeloid cells represent an important anti-tumor barrier, whereas our data identify CD8 + T cells as the crucial cellular component of inflammation-associated hepatocarcinogenesis.
LTβ, a central member of the TNF family, is secreted by lymphocytes, whereas LTβR is expressed on hepatocytes, stromal, epithelial and myeloid cells, implicating that LTβ signaling functions as a critical mediator between lymphocytes and the surrounding parenchymal and immune cells (Browning and French, 2002) . Long-term activation of LTβ signaling induces liver inflammation and fosters hepatocarcinogenesis, thereby causally linking hepatic LTβ signaling In summary, our results reveal that lymphocytes significantly contribute to liver damage and hepatocarcinogenesis, but also protect mice from acute on chronic liver failure and support liver progenitor cell proliferation during chronic liver injury. These findings emphasize the fundamental requirement that the immune system needs to be tightly regulated in a context-specific fashion, in order to balance immune surveillance and cancer risk. Moreover, inhibiting LTβR signaling might be an interesting approach to prevent tumor development in patients with chronic liver diseases accompanied by high levels of LTβ.
Experimental Procedures
Mice. All mouse experiments were performed according to the guidelines and with approval of Drinking water was supplemented with 2-(2-nitro-4-trifluoromethylbenzyol)-1,3-cyclohexandione (NTBC) at a concentration of 7.5µg/ml to simulate 100% NTBC treatment. Experimental setup was designed with repeated cycles of NTBC withdrawal and NTBC treatment. In Figure S1 the procedure of the cycling is pictured. Mortality rate of FCR mice was significantly reduced by treatment with co-trimoxazole during the first two cycles, therefore these mice were kept under antibiotic treatment for the first two cycles for all subsequent experiment. To exclude a direct effect of co-trimoxazole on the phenotype of Fah -/-mice, 30 mice were similarly treated with cotrimoxazole. There was not effect on survival or tumor incidence compared to untreated cycled Fah -/-mice. In order to track temporal changes on the quantity and composition of the normal gut microbiota compensation, community fingerprinting approaches based on 16S rRNA gene sequencing from fecal DNA was performed in healthy and cycled Fah -/-mice with and without antibiotic treatment ( Figure S5 ).
Synteny Analysis. In order to verify relevance of our mouse model in the human setting we downloaded the segmented copy number data of the Liver hepatocellular carcinoma data set along with the clinical data from the TCGA database. The data were called for copy number status using the R package CGHcall followed by the definition of copy number regions using the R package CGHregions . Synteny analysis was conducted as described in (Wolf et al., 2014) for the copy number regions obtained for the mouse model and for the following human hepatocellular data subsets: alcohol consumption derived, virus-derived and MYC-alteration derived. In order to assess the goodness of comparability we calculated the percentage of gains and losses in the mouse model that were also present in the human subsets of data. Further, the overlap of copy number changes between mouse model and human data was examined for statistical significance using Fisher`s exact test based on the null hypothesis "the overlap between copy number alterations in mouse model and human data occurred by chance". 
